Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

NX-DCP as a novel biomarker would be related to liver function in cirrhotic patients with hepatocellular carcinoma.

Hirano H, Saito M, Seo Y, Yano Y, Azuma T.

Eur J Gastroenterol Hepatol. 2013 Jun;25(6):748-9. doi: 10.1097/MEG.0b013e32835d91b8. No abstract available.

PMID:
23624798
2.

Des-γ-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma.

Tameda M, Shiraki K, Sugimoto K, Ogura S, Inagaki Y, Yamamoto N, Ikejiri M, Takei Y, Ito M, Nobori T.

Cancer Sci. 2013 Jun;104(6):725-31. doi: 10.1111/cas.12149. Epub 2013 Apr 21.

3.

Novel method to measure serum levels of des-gamma-carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: a preliminary report.

Toyoda H, Kumada T, Osaki Y, Tada T, Kaneoka Y, Maeda A.

Cancer Sci. 2012 May;103(5):921-5. doi: 10.1111/j.1349-7006.2012.02232.x. Epub 2012 Mar 8.

4.
5.

A combination of α-fetoprotein and des-γ-carboxy prothrombin is superior in detection of hepatocellular carcinoma.

Ertle JM, Heider D, Wichert M, Keller B, Kueper R, Hilgard P, Gerken G, Schlaak JF.

Digestion. 2013;87(2):121-31. doi: 10.1159/000346080. Epub 2013 Feb 8.

PMID:
23406785
6.
7.

Tumour-specific induction of immune complexes: DCP-IgM in hepatocellular carcinoma.

Beneduce L, Pesce G, Gallotta A, Zampieri F, Biasiolo A, Tono N, Boscato N, Gatta A, Pontisso P, Fassina G.

Eur J Clin Invest. 2008 Aug;38(8):571-7. doi: 10.1111/j.1365-2362.2008.01985.x.

PMID:
18625005
8.

Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma.

Uehara S, Gotoh K, Handa H, Tomita H, Senshuu M.

J Gastroenterol Hepatol. 2005 Oct;20(10):1545-52.

PMID:
16174072
9.

Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.

Durazo FA, Blatt LM, Corey WG, Lin JH, Han S, Saab S, Busuttil RW, Tong MJ.

J Gastroenterol Hepatol. 2008 Oct;23(10):1541-8. doi: 10.1111/j.1440-1746.2008.05395.x. Epub 2008 Apr 19.

PMID:
18422961
10.

Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients.

Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, Lok AS.

Hepatology. 2003 May;37(5):1114-21.

PMID:
12717392
11.

Des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma and liver cirrhosis.

Inagaki Y, Xu HL, Hasegawa K, Aoki T, Beck Y, Sugawara Y, Tang W, Kokudo N.

J Dig Dis. 2011 Dec;12(6):481-8. doi: 10.1111/j.1751-2980.2011.00521.x.

PMID:
22118699
12.

A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment.

Saito M, Seo Y, Yano Y, Miki A, Yoshida M, Azuma T.

J Gastroenterol. 2012 Oct;47(10):1134-42. doi: 10.1007/s00535-012-0577-0. Epub 2012 Mar 24.

PMID:
22441533
13.

Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size.

Nakamura S, Nouso K, Sakaguchi K, Ito YM, Ohashi Y, Kobayashi Y, Toshikuni N, Tanaka H, Miyake Y, Matsumoto E, Shiratori Y.

Am J Gastroenterol. 2006 Sep;101(9):2038-43. Epub 2006 Jul 18.

PMID:
16848811
15.

Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy.

Yamamoto K, Imamura H, Matsuyama Y, Hasegawa K, Beck Y, Sugawara Y, Makuuchi M, Kokudo N.

Ann Surg Oncol. 2009 Oct;16(10):2795-804. doi: 10.1245/s10434-009-0618-y. Epub 2009 Aug 11.

PMID:
19669841
16.

Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma.

Fujiki M, Takada Y, Ogura Y, Oike F, Kaido T, Teramukai S, Uemoto S.

Am J Transplant. 2009 Oct;9(10):2362-71. doi: 10.1111/j.1600-6143.2009.02783.x. Epub 2009 Jul 29.

17.
18.

A study about mechanisms of des-gamma-carboxy prothrombin's production in hepatocellular carcinoma.

Bertino G, Ardiri AM, Boemi PM, Ierna D, Interlandi D, Caruso L, Minona E, Trovato MA, Vicari S, Li Destri G, Puleo S.

Panminerva Med. 2008 Sep;50(3):221-6.

PMID:
18927526
19.

A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients.

Shimauchi Y, Tanaka M, Kuromatsu R, Ogata R, Tateishi Y, Itano S, Ono N, Yutani S, Nagamatsu H, Matsugaki S, Yamasaki S, Tanikawa K, Sata M.

Oncol Rep. 2000 Mar-Apr;7(2):249-56.

PMID:
10671666
Items per page

Supplemental Content

Write to the Help Desk